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The mic o b le-a ocia ed o ein Ta  (MAPT) la a c i ical ole in man
ne odegene a i e di ea e . Ta  f nc ion  o abili e mic o b le c e  ha  a e
e en ial fo  an o  i hin he ne on, and an o di ion lead  o lo  of
ne onal f nc ion. Ta  binding i  eg la ed b  ho ho la ion i h he hel  of kina e
ha  add ho ha e g o  hich block mic o b le binding i e , and ho ha a e
ha  emo e ho ha e g o  and e o e he mic o b le-binding egion . Ta  can be
fo nd in h e - ho ho la ed a e , hich ca e Ta  o elf-a emble in o
agg ega e  and e en  mic o b le binding. I '  clea ha  o - an la ional
modifica ion  (PTM ) of Ta  la  a ke  ole in he d eg la ion of ne onal f nc ion
d e o abno mal confo ma ional change , ho e e  no all PTM  a e a  ho o ghl
died a  ho ho la ion. N- e minal ace la ion i  he mo  common PTM of all
o ein  and Ta  i  edic ed o be a a ge . N- e minal ace la ion i  a co- an la ional
oce  ha  i  ca al ed b  N- e minal ace l an fe a e , hich add  an ace l g o
o he N- e min  of Ta , h  ne ali ing he o i i e cha ge on he N- e min .
Commonl , die  endogeno l  e e  Ta  in a oka o ic em ha  lack PTM .
U ili ing a co-e e ion em in E. c allo fo  he ifica ion of Ta  i h a
modified N- e min . P if ing modified Ta  i h Fa P o ein Li id Ch oma og a h
(FPLC) ill allo   o obe he c al and f nc ional effec  of N- e minal
ace la ion b  a e ing change  in Ta  agg ega ion and mic o b le binding affini





II. Tau Structure & Function
III. Post Translational Modifications
IV. Aggregation
V. Relevance of Stud ing the Effects of Tau s N-terminal Acet lation
Materials and Methods  19
Cloning Process
Single and Double Transformation
Induction Test
Harvesting Large Scale Inductions
His-tag Purification
TCA Precipitation
Real Time-PCR Aggregation E periment
Dial sis Aggregation E periment
Tubulin Pol meri ation Assa
Results .. 24
Transformation of Newl  Cloned Tau constructs (HB75 & HB76)
Induction Test of Transformed Escherichia coli
Large Scale Induction and Purification of His-tagged Tau
Tubulin Pol meri ation E periment
Aggregation E periments
Discussion . 29








I. N  D
Ne dege e a i e di ea e a e cha ac e i ed b e al a h ela ed ab al
ei d a ic d e a a a f i e ela ed fac (Ya a e al. 2000; A l ck e al.
2002; McKee e al. 2009; G i aldi e al. 2018; Ba d adh a e al. 2007). S e aj fac
a i cl de ida i e e , i ch d ial d f c i , di i i he e a i e k,
a d ge e ic . Ne dege e a i e di ea e a e cha ac e i ed ba ed he i e c bi a i f
he e fac , hich ca  be i e ela ed he e e ca e  he he  (Jelli ge , 2010).
O ida i e e efe he ed i bala ce i cell a d ga i , he e he
c ce a i f eac i e ge ecie (ROS) i i c ea ed a d bala ced b a i ida
defe e i de ai ai ed h e a i . Thi ca e a di ba ce i cell la e ab li
a d eg la i f cell la c i e , e eciall ei (B ei e bach a d Eckl, 2015). The
e e i e eciall e i i e a d ce ible ida i e e beca e i ake
a i a el 20% f he b d ba al O2 c i (Halli ell, 2006). Thi la ge a f
c i i d e he la ge a f ATP eeded aga e ac i e ial f
e e a d e all e ec e i (Halli ell, 2006). ROS a e i a il d ced f
e ca i g elec f he e i a chai eac i g i h ge i he i e e b a e f
i ch d ia d e a i i i ch d ial DNA, e al-i -a cia ed Fe eac i ,
li id e ida i , a d i ic ide i d ced ei i la i i e (Jelli ge , 2010).
The e ROS ha e h - elec i el idi e ei a d he ef e edia e ei
i f ldi g a d ei adical ha ca ca e a ca cade f e e ch a d eg la i f
calci h e a i , eac i e a gli i b h b e ed i e dege e a i (Jelli ge , 2010).
Addi i el , cell ha ca c ec hei ida i e i bala ce e e a i i h a id cell
dea h addi g  ida i e e  c ib i  e al dege e a i  (Jelli ge , 2010)
The i ch d ia i b h a i a d ce a d a ge f ROS. High le el f
ida ca i d ce i ch d ial e eabili a i i a d c le ida i e
h h la i i h ca a hic e ec i ch d ial e e ge ic a d e ab li , ea i g
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l e ed d c i f ATP, ha c ib e c ici ia a i (Jelli ge , 2010).
H e e , i ch d ial d f c i ela e ab al ei f ldi g beca e dec ea ed ATP
d c i ha h i c ea e he d c i f a l id β e ide ha ake a l id
ei la e (Jelli ge , 2010). The e a l id β e ide ca ea il e e he i ch d ia d e
he i c ea ed e eabili f i e b a e a d he ef e i d ce he d c i f f ee
adical , dec ea e c ch e ida e ac i i a d i hibi ATP ge e a i (Jelli ge , 2010). S i
a cle e e , i ch d ial d f c i a i c ea e ab al ei d a ic b al
ab all  f lded ei  i e ac  i h he i ch d ia a d f he  f el i  d f c i .
Di i f he e a i e k i babl e f he i a fac
e ai i g ab al ei i f ldi g beca e ei f a i i eg la ed b hi e k
(Jelli ge , 2010). The e k eg la i e ibili i l e ic c l f he
d c i , f ldi g, ab da ce, a d bcell la l cali a i f ei , a ell a ai e a ce
f ei c f a i (Klai e al. 2018). The b a ch f he e k, he i , i
c i ed f 279 c e , he ec d b a ch, f ldi g hich i f e c led i h a
a d a e bl , i c i ed f 332 c e , he hi d b a ch, deg ada i , i c i ed f
b h he bi i i - ea e a d a hag e ake a al f 1388 c e (Klai
e al. 2018). M lec la cha e e la a aj le i hi e k a he ac a liai
be ee he e k b a che a d e e he i f ldi g f di ea e-ca i g ei (Klai e
al. 2018). The f ldi g ce i i he e l e e d e he la ge be f ible
c f a i a l e ide ca ad (Jelli ge , 2010). The ef e, he he e k abili
c e i h he d c i f i f lded ei dec ea e i lead he ick acc la i f
he e ei ha a ac each he a d f le i a d agg ega e ha bec e ic he
cell (Jelli ge , 2010). The dec ea ed abili f hi e k i all ca ed b agi g hich
e l i he gai f a i i ge e ha e e he di ea e-ca i g ei a d fa l
lec la  cha e e  (Klai  e  al. 2018; Jelli ge , 2010)
S e f he e dege e a i e di ea e ela ed ab al ei d a ic i cl de
Pa ki di ea e (PD), H i g di ea e, Ch ic a a ic E ce hal a h (CTE),
Al hei e di ea e (AD), a d Ta a hie . Pa ki di ea e (PD) i c ide ed he ec d
c e dege e a i e di de (A l ck e al. 2002). PD all a ec e le i
la e ea f life i l i le e (S ei bj d i , 2016). PD i diag ed cli icall , ba ed
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he e e a i f , eci call he (S ei bj d i , 2016).
S e hibi ed ca be , he e a ea bef e
e a i g a ea l a 10 ea i (S ei bj d i , 2016). M ca be
l e f l a e e , c la igidi , e i g e , a d e i abili .
N - ca be lack f e i al i l e e a d i e e , e ce i e da i e
lee i e , lee  ble , a d c i a i  (S ei bj d i , 2016).
A. Pa  D ea e
PD i i a il he e l f da aged e a a idal e d e bi i
α- clei la e i cl i i he f f Le b die , h gh i ca a ec he e f
egi al e (A l ck e al. 2002). Agg ega i f α- clei i aid be ca ed b a
i e e a i a i i 53 (A53T) i i ge e a d gi e i e c ici ge e all
h gh i ch d ial d f c i , e d la ic e ic l e , ea e e
d f c i , a d i a a e e i ic glia (A l ck e al. 2002). Si ce PD i ca ed
b a ca cade f fac a d a ec l i le e f he b d he e i ea e a ailable
i l he g e i f he di ea e (S ei bj d i , 2016). H e e , ea e i h
d a i e gic d g a e ed elie e a d c ec di ba ce
(S ei bj d i , 2016). The e a e gical ea e a ailable, like dee b ai elec ical
i la i , b i i l ed f a elec g f a ie ha d e d d g he a
(S ei bj d i , 2016).
B. H  D ea e
H i g di ea e (HD) i a a al d i a i he i ed di de ha a
h i g a id-age a d dea h f ll e ha 10 20 ea af e e a iddle age
(Ya a A. e al. 2000). Thi i a a e di de ha i e ale i l 10 f 100,000
e le i he Ca ca ia la i (R , 2010). S ha cha ac e i e H i g a e
all i l a cha ge a d e e (R , 2010). D ia, hich i he
ig f H i g , ick , d k alki g, d a h ia, a d d hagia a e e f he
he ig (R , 2010). Beha i al a d chia ic e e ea l bef e
; The f e e ig i de e i , b he a e a a h , i ac i i , l elf
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e ee , a d feeli g f g il a ie (R , 2010). Diag i g HD i ba ed he
e e a i f cli ical de c ibed e i l a d he i di id al ha i g a a e i h
HD; I i e e iall ake a fa il hi f a e i h , beca e i h i
diag i  i   e  di c l  (R , 2010).
H i g di ea e i ca ed b he lack f c ica i be ee c ical a idal
e a d ia al edi i e (Ya a e al. 2000). The lack f c ica i
e l f he e a i f gl a i e e ea i he N- e i al egi f he h i g i ei
hich e i agg ega i d e a a i i he h i g i ge e (HTT) (Ya a e al.
2000).
The e i c e f HD b he e a e he a e ic a ailable f ea i g he
i c ea e e ali f life (R , 2010). The a ge ed e f ea a e he
e , d a i e ece bl cki g de le i g age a e ed ea he (R , 2010).
The g i f i di id al i h HD all e i h i c ea ed lack f c l a d
abili , e e all dea h cc beca e f c le e h ical de e de ce icide (R ,
2010).
C. C c T a a c E ce a a
Ch ic T a a ic E ce hal a h (CTE) i a e dege e a i e di ea e e ale i
a hle e la i g c ac like f ball a d i ili a e e a h e e i c ba e i g
(Fe ha aki-Zadeh, 2019). The di ea e i cha ac e i ed i 3 a ea ; The a ea i beha i al,
i cl di g agg e i , de e i , a a h , i l i i , a d del i ; The ec d a ea i
c g i i e, he e di i i hed a e i a d c ce a i , e de ci , e ec i e f c i i g
de ci , a d de e ia a e e hibi ed (Fe ha aki-Zadeh, 2019). M i he hi d a d la d ai
hich c i f d a h ia, gai ab ali ie , i c di a i , a d e (Fe ha aki-Zadeh,
2019). Ba ed he e di e e f he di e e d ai he e a e 4 diag ic
b e de ed, de i e, bable, ible, a d i bable CTE ha ca be de e i ed ba ed
he e i g a d f e e c f he (Fe ha aki-Zadeh, 2019). U f a el ,
c cl i e diag i f CTE i l acc li hed i h e a h l gical e a i a i f b ai
i e (Mckee e al. 2015). CTE e l f f al a d e al l be de e i a i , hi i g f
he h hala ic , h i kage f he a illa b die , all f he b a ia ig a,
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e la ge e f e icle, a d ed c i f b ai a e l i g f a iable a l id-β de i ,
TDP-43 i i e i cl i , a d e i e (McKee e al., 2009). H e e , he i a
ca e f a h l g i l cali ed e al a d glial acc la i f h h la ed Ta ( -Ta )
ha a a e b illa a gle (NFT) bef e f i g la e a d agg ega e (McKee e
al. 2009).
Thi di ea e ha al a bee k be a cia ed i h b i g a d f ball d e he
da age he e ca e i h e e i i e a a he b ai ; Thi a a i ha ca e he
acc la i f -Ta ha e l i e l gical de e i a i (McKee e al. 2009). Th gh
he e i e ea e f CTE, i bee aid ha a l i g a a ic b ai i j (TBI)
ea e i a i e e i i e a e a ide a iable i f h e ha e f i , a
ell a i le e a i f e e a i e ea e f a hle e a d ili a e el
(Fe ha aki-Zadeh, 2019).
D. A e e  D ea e
Al hei e Di ea e (AD) i e ale i he elde l , a d acc f 60-70% f
all de e ia ca e (G i aldi e al. 2018). S f AD a e he a e e e hibi ed i h e
i h de e ia (G i aldi e al. 2018). Diag i i c e l ba ed c g i i e a e e f
a ie e e i g a ic fea e f c g i i e a d beha i cha ge , bi a ke e i g f
ce eb i al id, a d MRI i age f he b ai (G i aldi e al. 2018 a d Ha e e al. 2017).
AD hall a k i c kele al al e a i e i g f he f a i f ab al Ta ei
c e i a fe e al e i he CNS. The e ab al f a i i cl de he
acc la i f a l id β la e e acell la l a d h e h h la ed Ta i acell la l
(G i aldi e al. 2018). Thei ec a e a l id ei a d e b illa a gle
(G i aldi A. e al. 2018). Ne al l f AD i di id al begi 10-15 ea i a
c g i i e i ai e (G i aldi e al., 2018). I e f c g i i e i ai e ha a e e,
h e i cl de beha i al a d c g i i e de ci  (G i aldi e  al. 2018).
The e i ' a e ec i e ea e l e e AD, a l f he ea e a e e ed
dif he g e i f he di ea e a ge , he acc la i f la e ; H e e , ba ed
he fail e f he e ea e i ial i a ed ha hi e f ea e al e i e ec i e
(Ha e e al. 2017). A l id β ei a e he ec f he la e ha f , he ef e
a ge ea e ha i hibi β a d α ec e a e e e iall e e hi ec ei
d c i , a d i c bi a i i h he f f ea e i ca i e c g i i e
a e e a d he e e ce f bi a ke . I , i he a i a he f f ea e .
I ili e a ib die a ge ed f di ea e ca i g Ta a d ce ai c f a i f a l id-β
e e he f a i f agg ega e a d la e a d i c ea e c g i i e a e e (Ha e e al.
2017). The e a e al - ha ace ical ea e ha i l e c g i i e ai i g f eadi g
a d eed ha ha e h i e c g i i e a d f c i al abili ie (Ha e e al. 2017). The
ai g al f ea e i e e iall e e a i e beca e ce he e a l id-β la e a d Ta
agg ega e ca e e al dege e a i , ha e al l ca be egai ed agai (Ha e e al.
2017). Th ea e f c e ed ci g he la e a d agg ega e bef e he bec e
e ic (Ha e  e  al. 2017).
E. Ge e a  Ta a e
Ta a hie a e a a ge f i c able a d g e i e age-a cia ed e dege e a i e
di ea e (C ghli a d I i , 2017). I di id al i h a a a h all e hibi a a ge f
ha ca be c g i i e a d/ hich c e i he f f e e e
i ai e (C ghli a d I i , 2017). Ta a hie a e cli icall a d a h l gicall di e e,
hich ake i ha d diag e; The ef e de i el diag e he eci c a a h a e
e ed f , a a i eeded c cli ical a a ical fea e (C ghli a d I i ,
2017). The e a ge f di ea e a e cha ac e i ed b he agg ega i f a i g Ta i f ha
a ea a la e i i iall . The e la e a e each a lec le ada a i f a
β-c f a i ; The e he agg ega e he e β- hee f Ta ack ge he i e
a d glia (Ba d adh a B. e al. 2007). A ke e a a h e k f i AD, h e e i
al e che a ec he e dege e a i e di ea e ch a PD a d CTE ha a e i l
e i ed Ba d adh a  B. e  al. 2007).
A al ead aid a a hie a e i c able b c i ed e ea ch ha h i i g
e l f ea e ial . O e ea e ech i e, ic b le abili i g age , ai ed
e e he l f Ta ic b le abili a i i a a hie ; I i ial die ha e bee
i i g b ha e c ce i g d fall like he ce al e e ide e ec ha e l
f e e i e e e abili i g age , like acli a el (C ghli a d I i , 2017). Ta
i he a ha bec e a he a ea f i e e i e f he a e ic ; I i i g e
del f di e e e f a f ag e ha h i e afe a d e cac f ed ci g
a  a h l g  (C ghli  a d I i , 2017).
II. T  S   F
Ta i a ei ha i hea il ela ed ic b le i e . Mic b le ha e e
d a ic egi ha la a chi ec al le i e a d all he achie e a d ai ai
e agge a ed ha e , hich i i a f a e ' c ica i di e e a f he
b d (De a d Baa , 2014). N l d he e e a a chi ec al le, b he al e e a
a a i le; Mic b le ac a high a he e lec la ei c e ca g
(De a d Baa , 2014). Ta i he f c i al ic e f ic b le beca e i i a
ic b le a cia ed ei ha abili e a d e ic b le l e i a i i
e (D bi a d Ki ch e , 1986). Ta abili e ic b le b e e i g
de l e i a i b l i g he a e f a i i he di a e bli g a e d (D bi a d
Ki ch e , 1986). P i a il , ake a ei , he a c i i f he Ta ge e i e e ial. Ta
i a c ibed f he MAPT ge e ha l ca ed ch e 17 i h a (Ada e al.
2010). J like a he RNA a c i , Ta RNA de g ce i g bef e i i a
a la able a c i . M e eci call , al e a i e lici g i a ce i g ech i e ha
ake di e e a ia f Ta . The clea RNA f Ta c ai i di e e i f , d e
al e a i e lici g; The e i f a e cha ac e i ed ba ed he he he lack c ai
e 2,3, a d 10 (Ada e al. 2010). Re ec i el , be ide he he 3 ic b le-bi di g
egi ha a e a ce Ta , e 10 c de f a ic b le-bi di g egi ha i i ila
he he 3 (Ada e al. 2010). The ef e, Ta i f ha c ai e 10 ha e 4
ic b le-bi di g egi (4R), a d h e ha d c ai 3 ic b le-bi di g egi
(3R) (Ada e al. 2010). D e he al e a i e lici g ce f Ta RNA, ei
d ced f  di e e  i f  di e  i  i a c e beca e he  c ai  di e e  e .
A. P a  S c e
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The i a c e f he Ta ei i di ided i a N- e i al a d C- e i al
egi (Ada e al., 2010). The e a e 11 c e ed e id e i Ta ha ha e ee be
i a i le; M11, A152, K174, S214, T231, R279, K280, C322, N368, S409, a d D421
(A ila e al. 2016). Whe a ca ed Ta ei a i h e hi i e-11, i e l i a cha ge
i he e ia c e f Ta (Ca el e al. 1996). Whe l i e-174 i ace la ed i e l i he
d c i f a ic ei (Mi e al. 2015). Se i e-214 h h la i ha a i i e e ec
he ic b le bi di g a i f Ta (Sc e al. 1993). Th e i e-231 de h h la i
ca e iall ake he ei ic beca e f i a ial e ec 2 li e e id e e i
(Ille be ge e al., 1998). A gi i e-279 dea i a i c ld facili a e he elf-agg ega i f Ta
(Da e al. 2013). L f L i e-280 a d ida i f c ei e-322 b h e c age he
f a i f Ta la e (G k e al. 2016) . Clea age f A a agi e-368 e l i ic
f ag e a i (Zha g e al. 2014). Se i e-409 ha a a i f he Rh ki a e, hich i c ea e
likelih d f Ta h h la i ; Ph h la i dec ea e he likelih d f deg ada i a d
e l i Ta acc la i (A a e al. 2003). La l , he ca i f a a ic-421 aid i
Ta  agg ega i  a d ici  (Ba -I la  e  al. 2016).
Ta i i a il e e ed i e (Mel e al. 2016). The e e i f Ta i ic l
eg la ed beca e i di e e i f i e ac i h ic b le i di e e a (Pa da e al.
2003). Si ce Ta lack h d h bic e id e , i cha ac e i ed a a i i icall di de ed
ei ; C bi i g hi i h he fac ha i c ai ic b le-bi di g egi e ea , i ha
he abili bi d di e e he e di e f b li a he ic b le la ice (Mel e al.
2016).
III. P  T  M
O ce a ei i a la ed a d e e bef e i f ld i i e c f a i , i
all de g e - a la i al di ca i . The e che ical di ca i ca be
e e ible i e e ible addi i f che ical g , li id , ca b h d a e , e e e id e
l e ide chai (U e k , 2013). J like lici g, PTM e e e a a f di e if i g he
di e e e f l e ide ha ca a i e f e RNA a c i f a a ic la ge e
(U e k , 2013). Re e ible PTM all ac a i che f ei , i g i i
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ca ie i f c i a d i g i i cha ge c f a i a d i able f c i ;
The addi i e al f a a ic la che ical g ca la ei he le (U e k , 2013).
Th gh PTM ca cc a a age i a ei ' life, he i e he a PTM i ca ied
de e i e ha le i la f he ei (U e k , 2013). Whe i i ca ied i he
al c f a i f a ei , i le i al e he f ldi g e cie c a d abili f he
ei a d he ef e de e i i g he e i ill e ide i he cell (U e k , 2013). If he PTM i
ca ied af e he ei ha f lded a d ha a de e i ed l ca i i he cell, i le i
ac i a e  i ac i a e he f c i  i  ed  ca   (U e k , 2013).
A. P a
The f c i f Ta , hich i he abili a i f ic b le f e h gh
bi di g, i d i e b he a la i al di ca i (PTM) f i highe de c e.
N abl , Ta ki a e ha e 4 h h la i i e , Se 262, Se 293, Se 324, Se 356 , all
l ca ed i all f ic b le bi di g e ea ; A d he he e i e gai a h ha e g i
dec ea e Ta bi di g a i ic b le (D e e e al. 1995). The e a e h ee ge e al
g f ki a e : li e-di ec ed e i e/ h e i e- ei ki a e , - li e-di ec ed
e i e/ h e i e- ei ki a e , a d ei ki a e eci c f i e e id e (Pa del e al.
1993; Dill e al. 2020; Lee e al. 1998). The e f ki a e h h la i c ela e
Ta le i abili i g a al a . Ta bi di g b li i e fe e i h he a al
a f ei ; a d he ce ai ei e c e Ta a ic b le
he fall (Di i e al. 2008). The ef e, h h la i e e ha a f he a f
 ei  a eli g  ic b le , e e i g he  f  falli g  (Al  e  al. 2004)
The eg la f c i f he h h la i PTM l e i e ki a e ei ,
b al ei h ha a e. P ei h ha a e 2A acc f he aj i f he
h ha a e ac i i f Ta (G g e al. 2000). Th gh e ea ch i bee ee ha l ca
h ha a e 2A (PP2A) de h h la e h h la i i e , b i ca al e e he abili
f i f lded Ta  ei   bi d  ic b le  (Wa g e  al. 2007).
N e hele , h h la i ca bec e a d eg la ed ce e l i g i
h e h h la i beca e f he d eg la i f PP2A (T ji e al. 2005). I a
di c e ed ha h e h h la ed Ta i a i g ca e f Al hei e di ea ed (AD)
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b ai ; The al b ai c ai Ta ha ha 2-3 le f h ha e e le f Ta , hile a
AD b ai ha 4-f ld ha a (K ke e al. 1993). H e h h la ed Ta l e i f c i
beca e i l e i a i ic b le hile i l a e l i g elf- l e i a i
(Al e al. 2018). I aid ha h e h h la i cc bef e agg ega i a
beca e i i el cha ged ic b le-bi di g d ai , hich i hibi elf-a e bl , ac i e a
ega i e cha ge he he a e h h la ed; Thi gi e h e h h la ed ega i el
cha ged Ta a a ac i i i el cha ge egi f he Ta lec le (Al e al.
2018).
B. G c a
A he e f a la i al di ca i ha a ec Ta i gl c la i hich
k i c ce i h h h la i , eci call h e h h la i . Gl c la i
i l e he addi i f a ga all he a a agi e e id e f Ta (N-gl c la i )
(Li e al. 2002). Ca b h d a e bei g la e i ie a d e e iall ega i el cha ged, ha he
e ial g ea l a ec he c f a i al d a ic f Ta a d i h . I ha bee f d ha
he gl c la i f Ta cc i h e h h la i i Ta , he ef e la i g a le i
i facili a i (Li e al. 2002).Thi i beca e ei ki a e ha e h ha e a g ea e
a i f gl c la ed Ta ha al Ta (Li e al., 2002). H e e , he e a e di i c
e f gl c la i ha cc i Ta ; N-li ked gl c la i hich add accha ide
h h la ed Ta eci call , a d O-li ked N-ace l- D- gl c a i e ha eci call add
ga   al Ta  (Li  e  al. 2002).
The al ce f N-li ked gl c la i begi i he e d la ic e ic l he e
a ga i a fe ed a l e ide i h he hel f a lig accha l a fe a e (Zieli ka e
al. 2012) . O-li ked N-ace l-D-gl c a i e cc i h he hel f a β-O-li ked
N-ace lgl c a i ida e ha i all l cali ed i he c la a d ha a i ila d a ic
 h h la i  (Well  e  al. 2001).
C.Ub a
Ubi i i a i i a ei di ca i ha k a k a f lded i f lded
ei hich he ge eli i a ed b a ATP-d i e bi i i ea al e (UPS)
13
(Pe celli e al. 2004). CHIP (ca b l e i f H c-70 i e ac i g ei ) di ec l
bi i i a e Ta i he e e ce f a E2 c j ga e (Pe celli e al. 2004). H e e , ba ed
i eac i i e e i e f AD a d Pick e , Ta le i e e f d be i i e
f bi i i , he ef e c ela i g bi i i a i he elf agg ega i f Ta , i ead f i
deg ada i  (Pe celli e  al. 2004)
D. N- e a  Ace a
The lea died b c a la i al di ca i f ei i
N- e i al ace la i hich cc c - a la i all i h he ei (A e e e al. 2009).
N- e i al ace la i i l e he a fe f a ace l g f ace l-c A a ala i e
e id e f he N- e i al egi f he ei he e i bec e c ale l b d (A e e e al.
2009). The ei e e e ible f hi di ca i i called Na A, i ac a a a f
ei i h N- e i i c ai i g e i e, ala i e, h e i e, gl ci e, c ei e, ali e i
h a (A e e e al. 2009). H e e , i ha bee h ha he eci c ace la i f l i e
e id e K280 b h eake Ta abili bi d a d abili e ic b le a ell a e ha ce
Ta agg ega i (C he e al. 2011). Whe i i el cha ged l i e e id e f he N- e i al
egi f Ta i ace la ed, i e ali e ha cha ge a d he e l i g ace la ed Ta ill ac
i ila he a i a d e agg ega i (Ka ah e al. 2014). A Ta ei ha a i i el
cha ged N- e i al egi a d ega i el cha ged C- e i al egi ; S he ace la ed ecie
ha l ca ie a ega i el cha ged d ai ill ha e a elec a ic a ac i he
i i el cha ged N- e i al d ai f ace la ed Ta ei , he ef e ca i g he
ge e a i f e b illa a gle a d agg ega e (R e be g e al. 2008; Ka ah e al. 2014).
N l d e ace la i e agg ega i , b i al e e he deg ada i f i f lded
a d agg ega ed Ta ecie b e e i g he bi i i a i a d b e e abili a i f Ta
b  he UPS (Mi  e  al. 2010).
O he he ha d, N- e i al ace la i f Ta k i c ce i h he
di ca i ch a ca i . T ca i f ei he he C- e i al b h egi f Ta e l
i he gai f a ic f c i , elf-agg ega i . E e , h gh e e i e a i , ace la i f
ca ed ecie f Ta a he Gl -124 e id e ha e h bi d a d abili e ic b le
e ha  ace la ed ecie  (De i b g e  al. 2015).
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I . A
A. H e -O de ed S c e
Th gh Ta i i i icall di de ed, lacki g e ia c e, i ha he ca abili f
f i g a e a c e like di e , lig e , a d la ge l e ha a e cha ac e i ed
a a h ge ic Ta c f a i h gh i e ac i i h i ic b le bi di g d ai .
The e i e ac i a e ade ible d e he c ei e e id e ha a e e e i he
ic b le bi di g d ai f he ei (S eda e al. 2015). The bi h ic a d bi che i
e ea ch f M ej de Ga ci i h ed ha a la e a d f ag e a e ble i a
a i- a allel a a ge e i g he ic b le-bi di g d ai (1986). H e e , he he
d ai a e acce ible d e i bei g b d a ic b le, a ei ill d a a
i e ac  a d f  di e  i g hei  N- e i al egi (M ej  de Ga ci i. 1986).
Bef e Ta f a e a c e i i h he i ed ha he e i a a i i a
echa i ha cc i , li id:li id ha e e a a i . Li id:li id ha e e a a i
(LLPS) i he f a i f e b a e-le ga elle ha e a a e a d c a e ali e
bi l gical c i e , like ei a d eac i , hich i e e ial f cell (Ka aa e
al.,2020). LLPS f Ta ha h be i e ced b he elec a ic i e ac i f i
d ai , i a la i al di ca i , a d i e ac i i h b li (Ka aa e al. 2020).
Thi gge ha Ta a ha e addi i al f c i abili i g a d i g b li
l e i a i beca e i f he e e b a e-le ga elle , gge i g ha a be hei
agg ega e  d  a  ell (Ka aa  e  al. 2020).
I i die ha f LLPS Ta i g ild- e Ta a d a Ta ha e e e
a h ge ic di ca i f Ta a h i l gical c ce a i h ha di ea e-like
di ca i ac all i c ea e a d e ha ce LLPS i i (Ka aa e al. 2020). Whe LLPS
a Ta i i c ba ed f l ged e i d f i e i ed ce he e e f l ble Ta i
he d le a d i c ea e he eedi g a d f a i f eci c a h ge ic c f a i Ta
ha  a e ic i   he ge e a i  f Ta  la e (Ka aa  e  al. 2020).
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B. F a
S c all , ha d i e he f a i f agg ega e a e 2 i e id e eg e : VQIINK
a he a f e ea 2 a d VQIVYK a he a f e ea 3 f he ic b le bi di g d ai
(Seidle e al. 2017). Th gh elec di ac i , a ic e l i f b illa c e
e ealed ha VQIINK eg e f igh e e ic i e i e face ha he VQIVYK a d
adhe e e he Ta e ide ha he VQIVYK a ell (Seidle e al. 2017). F he
e ide ce hi adhe i beca e e gi ee ed Ta c c l c ai i g ei he
eg e h ed ha VQIINK c c agg ega e e a idl ha he ild e
VQIVYK c c ha d ced a i e f Ta ecie ; M e , lig e , a d be
(Seidle e al. 2017). Ph i l gicall , he he i e i e face adhe e he Ta ei i
c ea e a Ta b il c ai i g a c e c ed f e ea 3 a d 4 f he MTBD (Seidle e al.
2017). Maj i f he c e c ai ed VQIVYK eg e hile he VQIINK eg e c a ed
b il (Seidle e al. 2017). Ba ed he eedi g e e i e , VQIINK i hibi e e e
e ec i e a e e i g eedi g ha VQIVYK i hibi (Seidle e al. 2017). Thi led he
c cl i ha b h eg e ha e e a a e eci c le ha hel d i e agg ega i (Seidle e
al. 2017). VQIINK i e -i e face , hich c a b il , e e be e acce ible Ta
e i g eedi g, hile VQIVYK i e i e face , hich f he c e, e e
a a l e -e cl ded ca ldi g cl e i g he b il ge he i a e c ac ha e,
ba icall d i i g a d abili i g e ic a d a e a c e f a i (Seidle e al.
2017).
C.De c  f A e a ed Ta  S c e
The l e -e e g c e ha f he a ied ibili ie f gl b la Ta c e
ha e ec da c al ele e ; 11% helical a d 21% a i a allel β c e (P e al.
2019). The e all gl b la c e a e c ide ed c ac c ai i g 4 di e e ce
bd ai ha ha e a e ahed al a a ge e (P e al. 2019). The c e f he c e
c ai l i le β c e ele e (P e al. 2019). Thi c e a able f d e
e- ie a i f h d ge b d f i a- ei i e - ei c -β b di g, hich
e l i he ea a ge e f he N- a d C- e i al a d i e edia e d ai i a agg ega ed
gl b la  Ta  c e (P  e  al. 2019).
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D. R e f O e
Ta lig e ic ecie a e l he ce f c ici , a ed
e la e , b he e e e he a ie c e be ee e a d la ge highe
de agg ega e f Ta (La g a-Ree e e al. 2012). Thi i e e li ed he he ele a ce f
ei di ca i a d agg ega i i i e iga ed (La g a-Ree e e al. 2012).
Ph h la i f eci c h e i e e id e f Ta la e a d b il ha e led hei
lig e i a i (La g a-Ree e e al. 2012). O e all, he acc la i f lig e ic Ta e l
i beha i al de ci a d e al l ecedi g a f a i f e b illa a gle
(La g a-Ree e  e  al. 2012).
E. Ne c  f A e a e
I acell la agg ega i f Ta i ic d e i e e ce i e glia he
c g i i e decli e a d e dege e a i cc (Ba d adh a e al. 2007). Ba ed
c -i eci i a i f l ble Ta / b li a d b illa Ta / b li , l l ble Ta
c eci i a e i h b li ; Thi h ha Ta agg ega i di ec l a ec Ta f c i b
e e i g Ta f bi di g b li (Ba d adh a e al. 2007). Wi h l f b li
abili , ic b le c kele c e f e ca e l ca f c i like
a a i f ce ai lec le al g a , echa ical , a d ga i e he c la .
I acell la Ta agg ega e dec ea e cell la iabili ; I he e e ce f a clea ai T P 3,
a dead cell i dica , Ta agg ega ed cell e be he l cell ha ai c a ed cell
i h l ble Ta  (Ba d adh a  e  al. 2007).
Be ide he b i e ec e al a a d a , agg ega e e hibi hei
ici b he ha f l e ec i ca ha e he ge e f a e he e e i he cle
(Nie iad ka e al. 2021). Ta c ai a DNA bi di g d ai a d ca f ei -DNA
c le e . Whe d f c i al a h ge ic Ta e e he cle , i a di ch a i
ga i a i leadi g cell c cle e-e a d d eg la i f ge e e e i hich ill b i g
ab e fa l ei (Nie iad ka e al. 2021). Wi h ge e ic defec e i g, i ill
e e all lead he deg ada i f he Ubi i i ea al e a d f he acc la i
f agg ega ed i f lded Ta ei (Nie iad ka e al. 2021). Addi i all , Ta lig e
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ca i e ac i h he i ch d ia di ec l a d i i e ali ed i i e b a e, i d ci g cha ge
i i adhe i (Nie iad ka e al. 2021). Thi ca e e e g i ai e i e hich i
e e ial i  a al e i al  a d a e  (Nie iad ka e  al. 2021).
Agg ega e f Ta a e a iall li i ed ecie , c ide i g hei a ied i e a d
ha e. A a f he ici f he e agg ega e i i abili aga e he cell (Kf e
al.,2012). Cell-Cell aga i f agg ega e i facili a ed b he ake f Ta b il f he
e acell la ace; Ta b il a e e fec i e if l a h gh a i e eable cell
e b a e a d e e a cell (Kf e al. 2012). Si ce Ta b il a e he ec he
f a i f lig e ic a d la ge Ta agg ega e , e e i e a b il e e a cell a agg ega i
i d ce i e e i a cell ha e e e Ta . Beca e he e a h ge ic Ta ecie ca ead
f e e i ca ca e ide ead e al dea h a d dege e a i hich d i e he
g e i  f e dege e a i e di ea e .
.  R   S   E   T  N- A
Thi jec add e e ha e ec N- e i al ace la i ha Ta c all a d
f c i all , ba ed ible cha ge i agg ega i a d ic b le bi di g a i . P e i
e ea ch ha h ha N- e i al ace la i d e a ec Ta e i f agg ega e
a d he ef e a ec i f c i (De i b g e al. 2015; Fa i e al. 2019). H e e he e ha
bee ch e ea ch add e i g he eci c c al e ec N- e i al ace la i ha ha
lead i he f a i f a e c f a i ha lead ible agg ega i a d e ec
Ta  f c i .
T e e f ec a N- e a ace a c a e e c f a f
Ta   a a  a   e  a e a  a d dec ea e f c .
T e hi h he i di e e e e i e al ech i e ill be ed ch a NMR
ec c ; I ill a e he c al cha ge f he ace la ed e ace la ed ecie f
a ba ed he cha ge i he ag e ic i e ie f he a ic clei ha a e b ded
i cl e a ge each he d e ei f ldi g (H a d e al.1998). A he ec c
1
ech i e, Ci c la dich i (CD), ill ide a i al f he ec da c i i f
ace la ed a d ace la ed ecie f a , a d he he e helice β hee f a a e l
f ace la i ; c ide i g he gl b la c e f Ta c ai a ie ec da ele e
(Mic ai e al. 2015). The e c al a al i ill be d e Ta 1-100 ei f ag e ,
hich e e e a a h f he N- e i al egi f Ta al e, a d F ll Le g h Ta
e e e i g he e i e f he ei ace la ed a d ace la ed. A ei agg ega i a a
ill be ed e al a e he e i f F ll le g h Ta f agg ega e , i h a d i h
N- e i al di ca i .
The di e e ecie f Ta agg ega e ca he be i ali ed i g Na i e Gel
elec h e i . Thi elec h e i ech i e all f a ei e ai i i a al
a ce c al a e a i a el h gh a l ac la ide gel i h de a i g c a ed
a al SDS-PAGE ech i e (N ak ki e al. 2014). Na i e Gel elec h e i ill
i ali e he agg ega e ha a all f he Ta i ace la ed e ace la ed, a d
he he agg ega e a e l ble de e di g h he di e i g a le h gh he
gel. T c ela e c e i h f c i , e e i e al a a ch a ic b le bi di g a d
b li l e i a i a a ill a e he e ec he e c al cha ge f ace la i ha
Ta i a f c i (H da e al. 2017; S e al. 2012). All f he e e e i e al ech i e
ill ie i ge he ell a ab he e ec N- e i al ace la i ha Ta a eci c a
he eighb i g e id e i e ac i cha ge , ec da c i i , he f a i f
agg ega e , a d la l  f c i .
MATERIALS AND METHODS:
R  DNA
HB45: Na  A DNA i  Pe 15 Vec
HB75: Ta  1-100 DNA i  PET22 ec  i h C- e i al Hi - ag a d A icilli  ca e e
HB76: F ll le g h Ta  DNA i  PET22 ec  i h C- e i al Hi - ag a d A icilli  ca e e
C  P
1
P i e  e e de ig ed f  Ta  1-100 a d f ll le g h Ta  DNA c c  ha  i cl de
de ig a ed Nde1 a d Xh 1 c  i e  ha  c ela e i h he a e c  i e  i  he PET22 ec .
Wi h he e f RT- PCR, i e  e e added  he e d  f Ta  1-100 a d F ll Le g h Ta
c c  i  a a e  he e Nde1 c  i e a  a e ded  he begi i g f he c c  a d
Xh 1 c  i e  he e d f i , hile i l a e l a lif i g he be  f Ta  c c
c ie . The PCR eac i  c i ed f 5 L f O eTa 10  b e , 2 L f dNTP, 2 L f he
e gi ee ed f a d i e , 2 L f he e e e i e , 38 L f a e , 0.5 L f Q5 l e a e,
a d 0.5 L f ei he  f ll le g h Ta  c c  a d Ta  1-100. The RT- PCR f a e e i g
e e 3 i e  a d 30 ec d  a  96 ℃, 30 ec d a  55 ℃, a d 72 ℃ f  3 i e .
PCR d c  f Ta  1-100 a d f ll le g h Ta  DNA e e a f ed i h T  10 E. c li cell ,
cell  c e e  f  DNA e lica i . T a f ed cell e e g   a icilli  l ia b h
aga  la e . C l ie  f  a f a i  la e  e e g   i  3 L c l e  ade i h 3
L f li id L ia b h a d 3 L f a icilli  a ibi ic i  de   i c ea e he a  f
able DNA f  he liga i  a d dige  c ee  ce . A The  Fi he  Scie i c DNA
i i e  ki  a  ed  e ac  Ta  1-100 a d F ll Le g h DNA f  T  10 cell
(The Fi he , 2021).
T  cl e he c c  i  he Pe 22 ec , b h Ta  1-100 a d f ll le g h Ta  c c  a d
Pe 22 ec  e e dige ed. 1 L f b h Xh 1 a d Nde1 e e  each, 5 L f 10  C a
B e , 15 L f he de ig a ed c c   ec , a d 28 L f a e  a  i ed ge he , a d
i c ba ed a  37 ℃ f  45 i e   a  h . Ta  1-100 a d f ll le g h Ta  dige  e e liga ed
i h dige ed Pe 22 ec  a  he a ia e Xh 1 a d Nde1 c  i e . T  de e i e he a i
f c c   e 22 ec , calc la i  e e ade i g NEBi calc la . The  cce f l
bei g 7:1 f  f ll le g h Ta  a d 5:1 f  Ta  1-100. The liga i  l i  f  f ll le g h Ta
 cce f l liga i  i  he e 22 ec  c ai ed: 1 L f dige ed ec , 3 L f dige ed
f ll le g h Ta  c c , 2 L f liga i  b e , 13.5 L f a e , a d 0.5 L f liga e b e .
The liga i  l i  f  Ta  1-100 a : 1 L f dige ed ec , 2 L f liga i  b e , 0.5 L
f liga e b e , 1 L f dige ed Ta  1-100 c c , a d 15.5 L f a e . B h l i  e e
i c ba ed a   e e a e f  e e al h . Liga i i e  e e he  a f ed i
T  10 cell , he e he cell  had he la id  e ac ed i g he The  Fi he  Scie i c DNA
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i i e  ki , dige ed, a d i ali ed b  a 0.8% Aga e DNA Gel. Whe  Ta  1-100 a d f ll
le g h Ta  cce f l cl i g i  Pe 22 ec  a c ed b  he aga e gel, ck  f
a f ed T  10 cell  f cce f l a i  e e ade a d ed i  he -80 ℃ f ee e .
S   D  T
F  a i gle a f a i , HB75  HB76 e e a f ed i h DE3 E. c li cell , cell
c e e  f  ei  e e i . 50 L f c e e cell  a d 2 L f ei he  c c  a
i ed ge he  f  a al f 52 L. If i  i  a liga i a f a i , 10 L f i c ba ed liga i
i e i  i ed i h 50 L f c e e  cell  (T 10) f  a al f 60 L. The i e i  lef
 ice f  30 i e  a d hea  h cked a  37 ℃ f 90 ec d . T a f ed hea  h cked cell
e e dil ed i h 250 L f l ia b h, a d he dil i a  hake  f  a i a el  60
i e  a  37 ℃, 200 L f he dil i  a  ead  LB a icilli  aga  la e . The la e
e e i c ba ed a  37 ℃ e igh   a   e e a e f  48 h .
F  a d ble a f a i , HB75  HB75, a d HB45 e e a f ed i h DE3 cell . I  hi
ca e, 50 L f c e e  cell  a  i ed i h 2 L f ei he  Ta  c c  a d 2 L f he
HB45 c c , f  a al f 54 L. The a e ced e f  he i gle a f a i  i
f ll ed f  he d ble a f a i , e ce  a d ble a ibi ic LB aga  la e i  ed.
I  T
T  c  ha  a f ed DE3 cell  ca  d ce he de i ed Ta  ei , c l ie  f  i gle
 d ble a f a i  e e g   i  3 L f l ia b h a d 3 L f a icilli  e igh .
1 L f he e igh  a  dil ed i h 4 L f l ia b h a d 4 L f a icilli  a d all ed 
g  f  a i a el  a  h . O ce he O.D. eached be ee  0.2 A a d 0.4 A, 5 L f IPTG
a  added  he c l e  a d all ed  i c ba e f  a 1 h   24 h  i d c i . I d ced cell
e e i ali ed i g a 15% SDS-PAGE. A e i  de k ha  h  ha  Ta  i  80%
ace la ed he  d ble a f ed a d i d ced DE3 cell  a e a al ed b  a  ec c .
H  L  S  I
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F  a 3L  4L e igh  i d c i  f  b h he i gle a d d ble a f a i  f ei he  Ta
c c , 6 250 L ce if ge be  a e lled i h he e igh  i d c i  a d  a  10,000
RPM f  10 i  i  a S all ce if ge. The e a a a  e ed lea i g he elle  a d
a  e ai i g e igh  a  ed i  he ce if ge be  a d  agai . I  ake  a al f 3
i   elle  all he bac e ia f  a 4L i d c i . Pelle  e e a hed i h 75 L f a e
i g a a la a d 25 l i e . Re e i  id f  all 6 be  e e elle ed i  2 250 L
ce if ge be . The e a a  a  e ed a d he elle  e e e e ded i  25 L f
a e  each. The e e i  id a  a fe ed  2 50 l c ical be  a d  a  10,000
 f  a i a el  20 i e . The e a a a  e ed a d he elle  e e ed a
-20 C.
H -  P
T  if  e e ed Hi - agged ei   f f e elle , a FPLC (Fa  P ei  Li id
Ch a g a h ) ech i e a  ed. L i  b e  c ai i g 50 L f B e  A ( 50 M NaCl
1M T i  H 9.0), 1 ea e i hibi  able , a d 250 L f PMSF (0.04 g/ L) a  ed 
e e d 2 f e  elle , 25 L f  each elle . Each e e ded elle  a  ica ed a  80%
a li de, i h 15 ec d l e a d 15 ec d e f  a al f 1 i e a d 30 ec d . Af e
ica i , ce if ge be  c ai i g ica ed e e i  e e b iled f  ab  15 i e
i  a a e  ba h e le e e  a k il he e e a e eached ab  75-85 C. O ce c le e,
b h be  e e i edia el  laced  ice f  15 i e , he  ce if ged i  he S all a
18,000  f  45 i e  a  4 C. The e a a f  b h be  a  ca ef ll  e ed. If
he e a  a  e ce  f hi e eci i a e i  he b iled l a e e a a , he  he e a a  a
l e ed h gh a 20 ic  l e   a l e  l ck i ge i  a clea  50 L c ical be. Bef e
i g he FPLC, he UNICORN a  f a e a  b ed a d he Hi -Tag i ca i  c l
l aded. The a le l e a  adj ed  ab 1-2 L le  ha  he al a  f b iled
l a e. The a le i le  a  laced i  he 50 l c ical be f l a e. 3 c ical be  a  ed
 c llec  he  h gh, a h, a d el i . The  i le  had  a all  ed i  each
c ical be h gh  each age f he ch a g a h i ca i  ce he FPLC a
a ed. O  he el i  age, he UV a  i ed i  de   gage he   e he 
i le  i  he el i  c ical be. Whe  he UV a ed  eak 2-3 i  ha '  he  he i le
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a  ed  he el i  be, a d ce he UV e ed  he ba eli e, he  i le  a
laced i  he a e beake   e e  dil i  f he e ei  c llec ed.
TCA P
The el a e a  a fe ed  a 15 l c ical be a d dil ed i h l i  b e   a l e f 10
L a d   ice. 4.5 g a  f a i  lfa e a added g ad all  i  he 15 l c ical
be a  i  a ed i  a 4 ℃ f idge. I  a  he  lef  a e e igh . The e  da , 1 L f he
a le a  ali ed i  12-14 ic ce if ge be each. The ali  e e  a  13,000
 f  60 i e  a  4 ℃. The e a a  f  each be a  e ed a d ali  e e d ied
f  30 i e  a  95 ℃a d ed a  -20 ℃.
R  T -PCR A  E
S l i  e a a i  f  hi  a a  i cl ded aki g: Agg ega i  b e  (1 M T i  H 7.4, 4 M
NaCl, 292 M EDTA), 100 M DTT, 3 M Thi a i  T, 5 M He a i . C l a d Ta
ei  e a a i  i l ed aki g BSA ( 4 g/ l i agg ega i  b e ), a d l bili i g Ta
ei  elle  i  1 l f 50 M T i  H 8. U i g a 96 ell la e, each ell c ai ed a 200 L
eac i : 100 L f ei , c l BSA  Ta , 2 L f Thi a i  T, 2 L f DTT, 20 L f
He a i , a d 76 L f agg ega i  b e . The e all a a  k 20 i e  al hile bei g
held a  25 ℃ i h e ce ce eadi g  f 454 i g he Real Ti e-PCR.
D  A  E
All he el e  a le f  a  FPLC  a  i e ed i  a dial i  bi g bag, ealed  b h
e d , a d he  laced i  a  E le e e  a k f 0.1M h ha e b e  H. 7.0. The dial i  bag
a   i h a i  ag e  f  1 h . E e  h , he h ha e b e  i  he a k a
e cha ged i h f e h b e . Af e  ab  4 h , he dial i  bag a  lef   i  e igh .
The e  da , a a le f he hi e i ible agg ega e f  he dial i  bag e e laced  a
lide a d i ali ed de  a c f cal ic c e.
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T  P  A
S l i  e a a i  f  hi  a a  a  all ade ice a d i cl ded aki g: G-PEM b e  (80
M PIPES H 6.9, 2 M MgCl2, 0.5 M EGTA, 1 M GTP, 5% gl ce l), 100 M f i i e
c l acli a el, e igh  l bili a i  a d dil i f ace la ed a d ace la ed Ta
ei   a 10X c ce a i , 10 M  40 M, a d 4 g f b li  l bili ed i  1 L f
G-PEM. U i g a 96 ell la e, each ell c ai ed a 110 L eac i : bla k (110 L f ge e al
b li  b e ), ega i e c l (10 L f ge e al b li  b e  a d 100 L f b li ), i i e
c l (10 L f acli a el a d 100 L f b li ), Ta  (10 L f 10  Ta  a d 100 L f
b li ), a d ace la ed Ta  (10 L f 10  A-Ta  a d 100 L f b li ). All ell l i  e e
added a d i c ba ed a  37 ℃, e ce  f  he b li il he 96 ell la e a  laced i  he
la e eade . U i g a Bi e  la e eade , ea e e ki e ic  e e e   60 c cle
c i i g f 1 eadi g e e  30 ec d , ab ba ce a ele g h a  e  a  340 , a d i  a
e   hake ce a  he a  f he eac i  f 5 ec d .
RES LTS:
C   T  C   P 22 
O  i i ial g al a   ili e a i  ch a g a h  if  he Ta  ei . Thi
e i ed Ta  c c  i h a  a ia e a i ag a d e ch e he c l  ed Hi  ag
f d i  he ec  ET22b (Fig. 1A). Ta  e e ce e e a li ed b  PCR ili i g i e
i h Xh 1 a d Nde1 c  i e (Fig. 1B). We d ced  c c ; he e i e Ta  ge e
(FL-Ta ) a d he  100 a i  acid  (Ta  100). B h PCR a li ed f ag e  e e dige ed
i h he e ic i  e e  Xh 1 a d Nde1, a  a he Pe 22 ec   d ce c le e i g
ick  e d . Ne , i  de   e e e  liga i f PCR f ag e  i  he ec , di e e
a i  f dige ed ec , PCR d c , a d liga e e e a f ed i  c e e E. c li cell .
T  e e e  i e i , e l i g c l ie  had hei  la id  i ed a d e e bjec ed 
e ic i  dige  i h Xh 1 a d Nde1. Pla id  i h a c ec  i e  f  Ta 100 ld d ce
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a dige ed f ag e  a d 500b  (Fig. 1C) a d FL-Ta  ld d ce a f ag e  a d
1000b  (Fig. 1D), Take  ge he , he e e l  gge e ha e cce f ll  cl ed b h Ta
c c  i  a ec  ha  ill add a C- e i i Hi - ag  ei .
I  de   e e he liga i ,  cl i g, f PCR c c  i  he ec , a liga i
i e f dige ed c c  a d ec , a d liga e a  a f ed i h E. c li cell  a d
dige ed  c ee  f  he Pe 22 ec  a d Ta  1-100 c c . Dige  c ee  f c l ie  f
a f a i  h ed ha  a eci c a i  f c c a d ec  i  e i ed i  de  f  he
Ta  c c   liga e i  he Pe 22 ec . F Ta  1-100 a a i  f 5:1 e e ed he be
e l  i  he c ee ; Thi  i  he l  a i  ha h ed he  c l  g h, a d la e  ha
e e ed he c ec  ba e ai  le g h f  b h he Pe 22 ec  a d Ta  1-100 c c  he
i ali ed b  a  aga e gel (Fig. 1C). O  f he 8 c l ie  ha  e e elec ed a d c ee ed, he
5:1 a i  e e e ed half f h e c l ie  (Fig. 1C). O  f he 4 c l ie , 2 f he  h ed he
c ec  ba e ai  f  he ec  a d c c ; A ed a  i   he c ec  Ta  1-100
f ag e  f  c e  (Fig. 1C).
F  he f ll le g h Ta  c c , a a i  f 7:1 i  he l  liga i  a i  i  he
a f a i  beca e he e i  f ll le g h Ta c c  ha  a  ed bef e hi  ickel
c l  i ca i  a ach, a  cl ed i g ha a e liga i  a i . Wi h hi ,  f he 8
c l ie  c ee ed, 3 f h e c l ie  had he a ia e ec  a d f ll le g h c c  ba e
ai  (Fig. 1D). Thi  ea   l  a  he e a high be  f c l ie   c ee   he aga
la e, de a i g ig i ca  g h, b  cl e  40 e ce  f h e c l ie  c ai ed he
f ll le g h Ta  c c  i  he Pe 22 ec ; A ed a  i   he c ec  f ll le g h Ta
f ag e  f  c e  (Fig. 1D). O e all, he eci c a i  eeded  cl e Ta  1-100 i  a Pe 22
ec  a  5:1 (HB75), a d f  he f ll le g h Ta c c  i  a  a a da d 7:1 (HB76).
T   N  C  T   (HB75 & HB76)
O ce he Ta  c c  e e cce f ll  cl ed i he Pe 22 ec  i h a C- e i i
Hi - ag (HB75 a d HB76), i  a f a i  a d i d c i ca abili  eeded  be e ed i
de  f  i   be ible   ake la ge a f Hi - agged Ta  ei  i h a f ed E.
c li. The i gle a f a i  ha  ed HB75 a d HB76 la id  al e h ed ig i ca
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a  f g h  a icilli  l ia b h aga  la e  (Fig. 2A a d B). The d ble
a f a i  ha  ed HB75  HB76 la id  i h he HB45 la id , h ed le  g h
 he l ia b h a icilli  a d chl a he ic l aga  la e  (Fig. 2C a d D). The e e l  ca
be e lai ed b  he dec ea ed babili  f bac e i aki g  l  1 b  2 di e e
la id . I  ge e al, a f i g E. c li i h e l cl ed Ta  c c  i  ible, a d
he ef e i i g f  he i e i  f aki g Hi - agged Ta  ei  f  he ickel c l
i ca i .
I  T   T E che ichia c li
T a f ed E. c li cell  i h HB75 a d HB76 de e a all cale 5 L i d c i
 e  hei  i d cibili . Ta  lec la  eigh a ge  f  45-110 kDa a d e k  Ta
1-100 i  a  e e el  all ei  (Fi che  a d Baa , 2020). A  de a ed b  he ed a
i  a  ded ced ha   a 1 h  a d 24 h  i d c i  i h IPTG h  he e e ce f f ll le g h Ta
a  a i a el  70 kDa a d Ta  1-100 a  a i a el 11 kDa (Fig 3). C cl i el  hi
i igh  h ed  ha  he  la ge cale i d c i ake lace a  l e  like 3  4 L, i d c i
h ld be held f  a d a i  f 24 h  i  de f  f ll le g h Ta  a d Ta  1-100  be
e e ed a d acc la e i  a f ed cell .
L  S  I   P   H - T
Wi h a f a i  a d i d ci g ca abili  e abli hed, la ge cale i d c i  f b h
Ta  c c  e e ca ied   a  he d c i ce  f ace la ed a d ace la ed Ta
ei . Te a i el , Ta  ei  e e ed i h he C- e i i Hi - ag ill de g  a e ie  f
e  ha  a e c cial  e a a e Ta  f  a  f he cell la  c e  ha  aided i  i
e e i . The eci c c bi a i  f e  f ica i   el i  ide clea e  a d
clea e  a le  f e Ta  a  i  g e e  h gh each e , i h he clea e  bei g he
el i  e  (Fig. 4A a d D). The e f he ica i e  i   h icall  e   he cell
i  de   acce  he  c la  he e he e e ed agged Ta  ei  i . Th gh ica i
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ide  acce   he Ta  ei  i  d e  ece a il  e a a e he ei  f  he c de
c e  f E. c li.
The hall a k  f hi  i ca i  a e he b il, el i , a d ce if ge i  be ee  each
e   il ickel c l  i ca i . The b ili g e  ake  ad a age f he i i icall
di de ed c e f Ta . O e ld e ec  ha he  a ei  i  b iled i  h ld de a e
a d l e i  ha e, h e e  beca e l ble Ta  e d ge l d e  ha e a c e  ha e,
i  ill e ai  a ec ed he  b iled, a d aj i f he he  ei  f E. c li ill de a e
 f l i . Wi h he ce if ge i , h e ei ill e a a e f  he e a a  f
l  l ble Ta  a d he ef e e e e  he g e i e e  a d  b ai i g e Ta .
L ki g a  b h SDS-PAGE  f he Ta  c c  i ca i , he clea  di e e ce i  i  i
e ide  c a i g he ica i  a d b il la e  (Fig. 4A a d D). The l  i e  ei
ba d  e e  i  l a e a le  af e  b il a d ce if ga i ca  lec la  eigh  f a d
70 kDA a d le  ha  11 kDA (Fig. 4A a d D). Th e lec la  eigh  alida e a d c
he ded ced a e  f  F ll le g h Ta  a d Ta  1-100 i  he i d c i  e  (Fig 3).
C a a i el , l ki g a  he el i  la e  f b h c c , he e i  a  i c ea ed lack
f fai  ei  ba d  di g he e e  e i e a i a e 11 kDA a d 70 kDA
ei  ba d  (Fig. 4A a d D). Thi  gge  ha be ee  he b il e  a d he el i  e , he
aj i  f he ei  ha  ac all  a ached he ickel c l  e e he Hi - agged Ta
ei , hich e l  i  highe  e ei  (Fig. 4A a d D).
F c i g e  h  ch e ei   e l f  i g hi  ickel c l
i ca i  ech i e, i d c i  l e ha  h  be f aj  ig i ca ce.  I d ci g
c l e  a f ed i h HB75 f  24 h  a  highe l e , ide  highe   f e
ei . Thi  i  h  b  he di e e ce i  i eg a ed el i  eak  f a 3 L i d c i  ickel
c l  ch a g a h c a ed  he 2 L i d c i ch a g a h d i g high %B el i
(Fig. 4B a d C). The 3 L Ta  1-100 i d c i  ha  a i eg a ed eak ha  a  3.19 i  g ea e
ha  he 2 L i d c i  (Fig. 4B a d C). The a e e d a lie  f  he f ll le g h Ta , 3 L
i d c i  i eg a ed el i  eak a  3.15 i g ea e  ha  he 2 L i d c i  (Fig. 4E a d F).
Si ce i eg a i  e e e  he e e i  f he e el i  eak  i  l e, highe  i eg a i
ea  highe  l e  f e ei  c llec ed af e el i .
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T  P  E
We e  a ed  a e  he f c i  f he i ed ace la ed a d ace la ed Ta . T
achie e hi , e ili ed a b li  l e i a i a a . B ie , e i ed b li  a  i
l e i ed i  ic b le , i ce l e i ed ic b le ill ab b ligh  a  340 .
Pacli a el i  a k  b li  l e i i g age , a d e e e cce f l i  b e i g b li
l e i a i  cha ge  i  e  f O.D. a d a e e i e he  l e i a i  i  ac i el
cc i g e  a 30 i e i e f a e (Fig. 5C a d D). Ta  ill al  i d ce b li
l e i a i  a d  i i ial cha ac e i a i  h ha  he e i  a ligh  i c ea e i  he a e f
l e i a i  e  c l (Fig. 5C). I e e i gl , he  c a i g he e f a ce f
ace la ed a d ace la ed Ta  e cl i el , ace la ed Ta  h ed  i c ea e he a e f b li
l e i a i  e ha  ace la ed Ta , he ef e i g b li  l e i a i  (Fig.
5C). Th gh hi  c a i  i   a i icall  ig i ca i  i  e gh  be a  ade a e
eli i a  e l
While he e a  a  i c ea e i  b li  l e i a i , he e e  he i ed Ta  i
l e  ha  e ec ed. A be  f i fe e ce  ca  be i fe ed f  he e e l : he e i  
e gh l ble Ta  e e , Ta  ei  i  he l ble a le f ag e ed d i g l bili a i
e a a i ,  he Ta  ei  agg ega ed bef e i  a  added  he ell . We e l ed a
a le f he l bili ed Ta  b  SDS-PAGE a d ba ed  he i ali a i  he e e e ei
ba d  f lec la  eigh  l e  ha  70 kDa e e i  he a le  ed i  he b li
l e i a i  (Fig. 5E). Thi  alida e  ha  f ag e a i a d he ef e l  c ce a i  f
Ta  a e he  la ible e la a i  f  he lack f cha ge i  b li  l e i a i  he
b li  i  i  he e e ce f  e Ta  a le (Fig. 5E). O e all, he e l e i a i  e l
h  ha  he a a  d e  k, h e e , i  d e  eed e di ca i  i  e  f Ta  a le
e a a i .
A  E
2
We he  a ed  ee if  i ed Ta  c ld be ed  b e e agg ega e f a i  i
i . U i g he i ed Ta , e e f ed eli i a  agg ega i  e e i e   e al a e he
agg ega i  beha i  f Ta . We ili ed a d e, Thi a i S, ha  eci call  bi d  a d
e ce  he  i  bi d   agg ega ed Ta  be . We he  b e ed cha ge  i  e ce ce e
i e  a e  agg ega i  a e. We edic ed ha agg ega i  f i ed Ta  c ld be f ll ed
e  a  h l  i e cale a  a ic g a  c ce a i . I i iall  e ili ed he a i   i d ce
agg ega i  a d f d ha  agg ega i  cc ed e a h e  i e cale (Fig. 5A). We e
a ked if agg ega i  ld ake lace i h  he a i  a e  Ta  i a e abili   f
agg ega e . Vi ible agg ega i  cc ed e  af e 24 h  i h  he eed f a  agg ega i
i d ce  a  illig a  c ce a i  f ace la ed Ta  ei  hich a   ee  i  he c l
ei  (BSA) (Fig 5B.) I  all, i i iall  i  ca  be ded ced ha  he Ta  ei , he he  ace la ed
 ace la ed ha  a high e i   agg ega e i  he e e ce a d i h  a  agg ega i
i d ce  like he a i .
DISC SSION:
R    S   D  T T   
P  S
Bac e ia d  e f   a la i al di ca i  hei  ei  a  f e  a
e ka ic ga i  d ; The  a e e e iall  l ca ied  he  i '  eeded f  he bac e ia
ada a i   a  e i e  (Macek e  al. 2019). Maj i  f he di ca i  ac all  ca ied
 a e  i e ha  he  a e di c l   ee a e ec  b  c al  f c i al a al i
(Macek e  al. 2019). Thi  l  eak   he i a i behi d i g a ka ic e  
d ce la ge cale a  f he Ta  ei  i h a d i h  N- e i al ace la i , a d hi
all a  i h he a f a i al ca abili  f a ka ic e  like E. c li. A lab a
DNA a f a i  f E c li de e d   cha ce. Whe e i  eall  c  i  a  2 i a  i
i  he a f a i  ced e, he hea  h ck e a d he g h f a f ed cell   aga
la e . I '  bee  a ed ha  i g c e e  cell ha  all  f  he ab i  f a de i ed
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la id h gh he la a e b a e i h he hel  f Ca2+ i  a d addi g a hea  h ck e
e e  ha  he DNA i  ake   i  he c l f he bac e i  (Rahi adeh e  al. 2016).
B   e e ha  c e e  cell  a f  cce f ll a d ca  h ld  he la id
e  ge e a i  f ge , he  ha e  be g  aga  la e  ha  c ai  he a ibi ic ha
he de i ed la id ha  a  e c ded e i a ce f . S cce f ll  a f ed bac e ia ha e  be
able  cce f ll  f l ll  f he e e i e e  be c l able a d he ef e i d cible 
ake la ge a i ie  f ace la ed a d ace la ed Ta  ei , hich i   be ed i  di e e
a a . Wha  a  de c ibed a  he cha ce  f a cce f l i gle a f a i , he ef e he
cce f l a i cial d ble la id a f a i f E. c li e i e  d ble he a  f
cce f l f l ll e  f he 2 e i e e . O he c l  ha e h  ha  he cce
f e e c  f a i gle la id a f a i  i  4-6 f ld g ea e  ha  he f e e c  f a d ble
la id a f a i  (We  e  al. 1979). Thi ca  e lai  he l  be  f c l ie  f d
i  he d ble a f a i  la e  c a ed  he i gle a f a i  (Fig. 2).
I   I  M
K i g ha  i gle a d d ble a f a i  a e ible, he e  big
acc li h e  a  he i d c i  e . Thi  i  babl e f he  c cial e  i  he
h le ce  f ei  d c i  beca e hi  de e h  ch e ei  e e e g i g
 ge  i  he e d ba ed  he ickel c l  i ca i e h d, hi k f i  a  he a e-li i i g
e . Th gh e i  ial  f a i g i d c i l e  e c cl ded ha  high i d c i
l e  ield highe  e ei  ield. The ch a g a h i eg a ed el i  eak  h ed ha
he highe  he i eg a ed al e, he highe  he l e f ei  c i g  f he i le  d i g
he el i  e  (Fig. 4). The e ha e bee  a  c l bli hed ha  ha e e  ha  high
de i  cell c l e , efe i g  high O.D.,  ide high ield ei  (Si a ha ga , 2009).
H e e , he e a e a  challe ge  ha  c e ab i h i g high de i  cell c l e  a d
h e a e: he c al fea e  f he ge e e e ce bei g e e ed, he abili  a d
a la i al e cie c  f RNA, ei  f ldi g, deg ada i  f ei  b  h  ea e , a d
c d  age ici  f he ei   he h  (Si a ha ga , 2009).
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N  he challe ge  ha  eci call  e ai   f ll le g h Ta  a d Ta  1-100 i  ei
f ldi g a d deg ada i  f he ei  b  he h  ea e . If f ll le g h Ta  e e  be ade
b  e e  cell i  a high cell de i  c l e he he e ill be a  i c ea ed acc la i  f Ta  i
he c l e. C ide i g h  i i icall  di de ed Ta  i , a d i ca i  i e  ha  a e d e
 a e  agg ega i  he  c ce a i g high  f Ta  af e  el i  i g dial i  
a c ce a  be, e ca  afel  a e ha  Ta ld f  agg ega e  a d eci i a e he
e e ed i  a high de i  c l e bef e i  e e  de g  i ca i . Thi  c ld he ef e
ac i a e he ea e  i  he h  cell  ha  ld deg ade Ta  a d ge  id f he agg ega e . A
f  Ta  1-100, beca e i  i  ech icall  l  a iece f he Ta  ei  bei g e e ed, he cell
a  ec g i e i  a  a i a la ed ei  f ag e a d ac i a e he ea e  ca i g i
deg ada i . The ef e  c e ac  he high O.D. e ec  f i d c i , highe  l e  f
c l e a e i d ced e igh ; I  e  ha  he e highe  l e  ide highe  ield  f
ei , ba ed  i eg a ed el i  eak al e  (Fig. 4).
P  T
P ei  e e ed i  i d ced c l e  eed  be i ed  i  de  f  i   be ef l
a d ide clea  e l  f  c al a d f c i al a al i . O e f he ai  c al
a al i  ech i e  ha  ld ha e bee  ed  d ace la ed a d ace la ed Ta  i  NMR
a al i . NMR ec c  (N clea  Mag e ic Re a ce ec c ) ha  la ed a aj
le i  i i g he f a i  f di i c  a ec f ei  c e; I  f l ll  hi  le
h gh i  abili   a al e he di ib i  f h d ge  a d de e i  i  eadil  cha gi g
i e  i  ei  (D b  e  al. 1998). The ali f he c e  d ced b  NMR i
c a able  ha  f - a  c all g a h ; H e e , c al ali  i  de e de   he
e e  a d ali  f he da a ha  ca  be b ai ed, hich de e d   he i  f he ei
a le (M eli e e  al. 2000). Thi  i  h  he e f i ca i  ed  if  Ta  i  c i ical
a d i a , beca e i  de e i e  ha  he e l f a a  a d a al i  ill l k like. D e
 he de ig  f he DNA c c  i d ced i E. c li bac e ial c l e , he Ta  ei
e e ed ha  a Hi - ag  he C- e i i. Thi  a i ag ha  a e  high a i  f  Nickel,
hich i  ha  he c l  ed i  he ch a g a h e  i  ade f. Pa i g l a e  f he
a i  agged Ta  ei  e  he c l  e e ha  he  a high al  b e  i  ed 
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di l ca e a e ial a ached  i , he l  hi g ha  el e   f he c l  i  he Ta  ei .
I  h  ha  i g hi  a i - ag i ca i ech i e  if  ei   f c de a le
i  highl  e cie ; S eci call  i g he Hi - ag ech i e ide  g d ield  e e  he  i g
a  i e e i e a ib d  i ca i  ac ice (Lich e  al. 2005).
O e f he aj  c ce  e had i h he a i - ag ech i e i  ha  ce he e
ei  i  e ac ed f  he bac e ial c l e, e e e  e ha  he Hi - ag  e ec  ld
be  he ei  f c i ali  a d c al c f a i . A a  e f ed  a i ila
i i icall  di de ed ei , FUS i h he Hi - ag, h ed e di e e ce  i  e l  i h
he ag e   ag a  all (B ck e  al. 2020). Li id-li id ha e e a a i  e e i e  i g
agged a d agged FUS h ed ha  he Hi - ag e ha ced he e i  f he ei  
ha e e a a e, ace la ed  ace la ed (B ck e al, 2020). Wi hal, a e  e e ade 
clea e  he Hi - ag i g a TEV ea e e e, i ce he Ta - agged ei  ca ie  a TEV
e i e be ee  he C- e i i a d he Hi - ag. H e e , c e ciall  a ailable TEV ea e
i   a  a c ce a i  ha  i  ld be e ec i e a  clea i g  he ag   all he ei  i
 highl  c ce a ed el e . Al e a i e e ed  d ci g TEV ea e i  he lab,
h e e  he TEV ea e la id  ha d a   i d cible i  a f ed DE3 E. c li cell .
O  he c ce a i g e d, el e  c ce a i  a cce f l. High al  el i  f
Ta - agged ei  a  TCA eci i a ed, hich all ed f  he ali a i  f ei  i
la ge a i ie  f i di id al ic ce if ge be , hich  a e age eached ab  0.5-1 g/ l
f ei  f  each be.
E
U i g e Ta  f  he ickel c l  i ca i , a a  e e ill ca ied  f
eli i a  e l . The  agg ega i  a a  a a  i e i al e h d f f i g
eci i a e  f agg ega ed Ta  ba ed  c ce a i g high al  el e  f Ta  i g dial i . The
le  al  a d i ida le e e  i  he dial i  bag e l  i  cl e  i e ac i  be ee
Ta - agged ei . Ba ed  he gl b la  c e f Ta , he i  a e f he ei
all  f  e a d e ca ld   f  be ee Ta  ei  a  ell a  he f a i  f
la ge  agg ega e  he l ge  i  dial e  (Fig. 5B).
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U i g he b li  l e i a i  a a   l k a  he h he i  f  he f c i al
e ec i e, i i ial e l  e e  ig i ca . H e e , he e i  a f ld i c ea e di e e ce i  he
a e f l e i a i  be ee  he ace la ed Ta a d ace la ed Ta  ei . Ace la i
ee   e he b li  l e i a i  abili f Ta . I  i  afe  a e he e i  a
ibili  ha  ig i ca  e l  e e  a ai ed beca e f he c ce a i  f Ta  bei g
ed. Th gh c i e  bi g f TCA eci i a ed Ta  ei , ali  did  c ai  he
a e a  f ei . The c ce a i  a ged f  12-40 M, hi  c ld al e  e l  f
ial  ial he  e  ali  f ei  a e bei g ed f  each ial a a . F he e, ba ed
 he SDS PAGE f he Ta  a le  ed f  he a a , Ta  i  he l  ei  e e  i
he e a le  (Fig. 5E). P ei  f l e  lec la eigh  a e i  he a le , a d h e
ei  ba d  c ld e e e  f ag e  f Ta  e l i g f  i ea e  f l bili ed
a le . Thi  he  ca  e iall  be ed beca e i ali a i  f a he  l bili ed
TCA eci i a ed a le h ed di i c  a  f ea i g ha  c ld be deg ada i  (Fig.
4D) . Th e l e  kda ei  ba d  ca  al  e e e ei  f  he c de l a e a le
ha  a   i ed f  he Ta  ei  i g he Nickel c l  i  he i ca i .
F  
The i ca i  e h d l g  ed  b ai  e Ta eed   be di ed  b i g ab
c i e  a d clea  a le  f ei  ha  ca  be ed i  he l e i a i  a a  a d f e
e e i e . M di ca i  i cl de d i g 2  f he ch a g a h  i ca i  e ; The
  ill be d e i g he ickel c l  a d he ec d  ill be d e i g a
i -e cha ge C l . The Hi - ag  he Ta  ei c ai  i i el  cha ged hi idi e
e id e  ha  ill bi d  he i -e cha ge c l di e e l  he  he he  e a  ei  i
he a le ha  a  ha e had e a i   he ickel c l . S  he  ei  el e  f
he I -e cha ge c l  he  ill d   a  di e e i e  ba ed  hei  di e e ce i  cha ge a d
he ef e a i  (Naka a i e  al. 2012). The e ei ill be de ec ed h gh he UV de ec .
F ac i i g a le  d i g he el i  e  f  di e e UV eak  a  di e e  i e i , a d
i ali i g h e a le  b  SDS-PAGE ca  fea ibl di la  a ce ai  UV f ac i  ha  l
c ai  he ace la ed  ace la ed Ta  ei ba d. The  ba ed  he SDS-PAGE,
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ide if i g he i e i  he e he Ta  ei  al e el e   f he I -e cha ge c l
c ld ide clea e  a d highl  c ce a ed a le f e Ta .
C i i g  ble h  he Hi - ag e al e i g a TEV ea e i  ig i ca l
ece a  f   e Ta  1-100 ei , a he  ha f ll le g h Ta . Ta  1-100  e i
i a il  f  he c al a al i  f he N- e i al egi  f he Ta  ei ,  i h a
i i el  cha ged ag a ached  ch a all ei i  c ld d a icall  a ec  he NMR a d
CD a al i  ha  c ld e iall  be d e. The e e  f a al i  a e i a il  ba ed  he
che ical e ie  a d cha ge  f e id e  eighb i g each he  (H a d e  al. 1998). I
e  f he f ll le g h Ta , i g he TEV ea e  hi  ei  i   e i el  ece a ,
beca e he Hi - ag i   ea  he ic b le bi di g d ai  hich i  ha  Ta  e   ca
 i  f c i  a d agg ega i .
Maj i  f he e ea ch d e e  he c e f 4 ea  f c ed  e fec i g a
i ca i  ech i e ha  ca  be ed  ide he ibili  f  b h he c al a d
f c i al a al i  f Ta . Th gh he e a e e di ca i  a d f he  i e iga i
eeded, e f he f c i al a a  ha  ca  be d e i  he f e a e b li  bi di g a a
a d agg ega i  a a . The e  a a  a e a ke addi i   he l e i a i  e e i e
e f ed beca e e ca  deci he  he e ec  f N- e i al ace la i   Ta  a i  
b li  a d i  l e i a i  he   c a e a a e l . F he  a al i  f agg ega e
i g a  agg ega i  a a  ca  al  h  he e ec f ace la i . O  ha  a e e, i g
agg ega e  ha  a  f  f  he agg ega i  a a i  he l e i a i  a d bi di g a a
ca  ide ke  i f a i   h  ace la ed a d ace la ed agg ega e  a ec  b li
l e i a i  a d abili a i . S c al a al i like NMR a d CD f b h he FL Ta  a d
e eciall  Ta  1-100, c ld e eal a e  c ce  a echa i  behi d he d a ic  f
agg ega e  i h he added b   h  N- e i al ace la i  a ec  ha  echa i . O e all,
hi  i  all h i l gicall  ele a  beca e he d a ic f Ta  agg ega e  i  ha  d i e
Ta a hie . The ef e di g  h  N- e i al ace la i  a ec  Ta  agg ega i , b li
bi di g, a d b li  l e i a i  h gh c al a d f c i al a a  ca  e iall  lead
 a he  he a e ic ea e  ha  ca  be ed  ea  a la ge cla  f e dege e a i e






F  1. A. S    C  P   F  L  T   T -100  P 22
. B. PCR C  S   F  L  T C . To ensure that the PCR
performed was successful a DNA Agarose Gel was used to visuali e the presence of the
desired Full Length Tau constructs with the designated forward and reverse primers with Xho1
and Nde1 cut sites. C. D  S   T  1-100 C    L  R
(C   ). Selected colonies from the 5:1, 7:1, and 5:1 ligation transformations
were grown up into 3 ml cultures. The DNA from each of the cultures was e tracted and a the
DNA plasmids were digested to check for the correct insert construct, Tau 1-100. The digests
were ran through an agarose gel in 1X TAE Buffer, and visuali ed b  UV. D. D  S  
F  L  T  C    5:1 L  R . Selected colonies from the 5:1 ligation






F  2. S   D  T   E  P  S . A. S
T   F  L  T  . Transformation was done using DE3 competent E. c
cells and Full-length Tau PET22 His-tag vectors (FL-T PET22) that encoded a ampicillin
cassette for plasmid selection under conditions described in the Materials and Methods section.
Transformed cells were plated on Luria Broth (LB) Agar plates that contained ampicillin. B.
S  T   T  1-100. Transformation was done using DE3 competent E. c
cells and Tau 1-100 PET22 His-tag vectors (T-100 PET22) that encoded an ampicillin cassette
for plasmid selection under conditions described in Materials and Methods. Transformed cells
were plated on LB Agar plates that contained ampicillin. C. D  T   F
L  T   N  A . Transformation was done using DE3 competent E. c cells
and FL-T PET22 and a Nat A comple  construct (HB45) that encoded a chloramphenicol
cassette for plasmid selection under conditions described in the Materials and Methods. D.
D  T   T  1-100  N  A . Transformation was done using
DE3 competent E. c cells and T-100 PET22 and HB45 that encoded a chloramphenicol
cassette for plasmid selection under conditions described in the Materials and Methods.
3
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F  3. I   DE3 C  T   FL-T  T-100 C . 2 aliquots
of 5 ml cultures of Full Length Tau and Tau-100 were induced with IPTG for a 1 hr induction
period. A third 5 ml culture of Tau-100 was induced with IPTG for a 24 hr induction period. 1 ml
of each culture was l sed b  boiling, ran through a 4-20%  Coomassie blue SDS-PAGE, and








F  4. P  S   FPLC H -C M : T  1-100  FL T
P   3L I   C    I
. A. 3L P   T  1-100. 15% Coomassie blue SDS-PAGE was used to
visuali e  each step of the purification. 20 uL samples of the 3L induction of acet lated Tau-100,
l sed product, boiled product. 20 uL samples  from each step of the Fast Protein Liquid
Chromatograph  (FPLC) run was taken; Flowthrough, wash, and elution were sampled. B.
C   3L T  1-100 N  C  P . The chromatograph of a 3L
culture of induced Tau-100 demonstrates the nickel column purification process which includes
washing appro  50 ml of acet lated Tau-100 protein of impurities with low salt Buffer A (50 mM
Tris pH 9.0 50 mM NaCl) once injected into the column, and eluting the pure protein off of the
column with a high salt Buffer B (50 mM Tris pH 9.0 50 mM NaCl). The eluted protein passes
through a UV detector, a chromatograph containing UV peaks of material passing through the
detector were integrated. C. C   2L T 1-100 N  C  P .
The chromatograph of a 2L culture of induced Tau-100 that underwent the same nickel column
purification as in B. D. 2L P   FL T . An 8% Coomassie blue SDS-PAGE was used
to visuali e each step of the purification of a 3L. Sample prep was the same. E.
C   3L FL T  N  C  P . The chromatograph of a 3L culture
of induced full length Tau whose boiled l sates underwent nickel column purification using the
ACORN FPLC, same as B. F. C   2L  FL T  N  C  P .
The chromatograph of a 2L culture of induced full length Tau whose boiled l sates underwent








F  5. T  A   T  P  P  E . (A). 96
well plates contained full length Tau, heparin, Thioflavin T, DTT, and aggregation buffer bringing
the reaction volume for each well to 200 ul. Using Real-Time PCR the aggregation of Tau was
observed over the course of 0-1 hr. (B). Microscop images of acet lated Tau aggregates were
obtained b  using a dial sis bag stirring in 50 mM phosphate buffer that contained eluted
acet lated Tau. The formation of visible aggregates was observed over the course of 72 hours.
Bovine Serum Albumin served as a negative control.C. T  P  A . Using a
96 well plate and Bios stems plate reader, each well reaction contained 110 uL reactions. For
the positive control, a tubulin pol meri ation promoter paclita el was used. For the protein
samples, Tau and acet lated Tau was solubili ed overnight in G-PEM buffer. The overall assa
took 30 minutes with readings ever  30 seconds at 340 nm. D. L  G   P  C
 T  P  A . Change in O.D. for the positive control wells in the tubulin
pol meri ation assa s 1 and 2 recorded over a 30 minute period. E. T  P
P  S  G . Visuali ation of overnight solubili ed Tau and acet lated Tau samples
using 4-20% Coomassie Blue SDS-PAGE.
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